Case Discussions in PN: Managing Challenging Patients in the Continuum of Care (CE/CME Webcast)
Activity Description and Purpose
Experts discuss challenging cases in adult and pediatric/neonatal parenteral nutrition (PN), providing evidence-based best practices and practical approaches for incorporating lipids into PN regimens for hospital and home adult patients and hospital pediatric/neonatal patients. Topics include avoidance of essential fatty acid deficiency, managing patients at risk for intestinal failure–associated liver disease, and appropriate use of lipid injectable emulsions in a variety of patients. This webcast captures the proceedings from a CE/CME symposium held at ASPEN 2023. The desired results of this educational activity are to increase knowledge of best practices in PN, thus increasing competence among clinicians in dosing and providing lipid injectable emulsions safely in adult and pediatric patients.
This educational activity is intended for dietitians, pharmacists, nurses, and physicians engaged in the care of adult and pediatric/neonatal patients requiring parenteral nutrition.
After completing this activity, participants will be better able to:
- Describe the dosing of various lipid injectable emulsions to prevent essential fatty acid deficiency in adult and pediatric patients
- Demonstrate appropriate use of lipid injectable emulsions in hospital and home adult patients
- Demonstrate appropriate use of lipid injectable emulsions in pediatric/neonatal patients at risk for intestinal failure–associated liver disease
|Carol Ireton-Jones, PhD, RD, CNSC, FASPEN (Chair)|
Nutrition Therapy Specialist
Good Nutrition for Good Living
Adjunct Graduate Instructor
Department of Nutritional Services
Texas Tech University
Phil Ayers, PharmD, BCNSP, FASHP
Kara Calkins, MD
|Daniel Robinson, MD, MSc|
Associate Professor of Pediatrics (Neonatology)
Northwestern University Feinberg School of Medicine
MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.
Phil Ayers, PharmD, is a consultant for Fresenius Kabi USA; is an advisory board member of Fresenius Kabi USA; and is on the speakers bureau for Baxter* and Fresenius Kabi USA.
Kara Calkins, MD, is a consultant for Baxter and Fresenius Kabi USA; is on the speakers bureau for Fresenius Kabi USA; and is a contracted researcher for Mead Johnson & Company, LLC.
Carol Ireton-Jones, PhD, RD, is a consultant for Nutrishare Inc; and is on the speakers bureau for Fresenius Kabi USA.
Daniel Robinson, MD, MSc, is a Data and Safety Monitoring Board member of Fresenius Kabi USA; and is a contracted researcher (institutional principal investigator) for Mead Johnson & Company LLC.
* The financial relationship existed during the past 24 months but has now ended.
This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.
Planners, Managers, and Writers
Carrie Allen, PharmD, BCPP, BCPS, MedEdicus Content Manager for this activity, was previously employed by CVS within the past 2 years, but that relationship has ended.
Other MedEdicus planners and managers have no relevant commercial relationships to disclose.
Learners must view the webcast and complete a posttest and evaluation form to receive a certificate of completion. You must view the entire webcast as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Dietitians (CDR) Credit Designation
Amedco LLC designates this activity for a maximum of 1.5 CPEUs.
For Pharmacists and Nurses
Interprofessional Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by MedEdicus LLC and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 1.5 knowledge-based CPE contact hours.
Event UAN: JA4008163-9999-23-096-H99-P | UAN JA4008163-9999-23-096-H99-T
The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.5 ANCC contact hours.
ACCME Accreditation Statement
MedEdicus LLC is accredited by the ACCME to provide continuing medical education for physicians.
AMA PRA Credit Designation Statement
MedEdicus LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support
This continuing medical education activity is supported through an educational grant from Fresenius Kabi USA.
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at email@example.com.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC, Amedco LLC, or Fresenius Kabi USA.
©2023 MedEdicus LLC. 295.2
- 1.50 ACPE
- 1.50 AMA PRA Category 1 Credit™
- 1.50 ANCC
- 1.50 CDR
- 1.50 Participation